London, United Kingdom

Timothy John Ritchie

This inventor holds 1 USPTO granted patent. Top assignees: Imperial College Innovations Limited, Myricx Pharma Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy John Ritchie. Retrieved from https://idiyas.com/inventor/timothy-john-ritchie-wkwjo21z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy John Ritchie

Introduction

Timothy John Ritchie is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative work on Imidazo[1,2-a]pyridine compounds. His research has the potential to impact various therapeutic applications.

Latest Patents

Timothy John Ritchie holds 1 patent for his invention titled "Imidazo[1,2-a]pyridine compounds and their use in therapy." This patent relates to compounds of Formula (I) and explores their various therapeutic applications.

Career Highlights

Throughout his career, Ritchie has worked with prominent organizations, including Imperial College Innovations Limited and Myricx Pharma Limited. His work in these institutions has allowed him to further develop his innovative ideas and contribute to advancements in medical therapies.

Collaborations

Ritchie has collaborated with esteemed colleagues such as Edward William Tate and Andrew Simon Bell. These partnerships have enriched his research and expanded the scope of his inventions.

Conclusion

Timothy John Ritchie is a distinguished inventor whose work on Imidazo[1,2-a]pyridine compounds showcases his commitment to advancing therapeutic solutions. His contributions to the field are noteworthy and continue to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…